Among the >20 histone biomarkers evaluated, our findings revealed significant alterations in four specific histone modification/modifier pairs (H3K4me2/LSD1, H3K9me2/G9a, H3K36me2/NSD1, DNMT1) across the four major BC molecular subtypes. The gene discussed is EHMT2; the disease is breast cancer.